In contrast, expanding the clinical spectrum of the EMC10‐related NDD, the cases reported here presented with dysarthria, persistent peripheral hypotonia, movement disorders, gait ataxia, and vermian atrophy together with noticeable growth impairment, and hyperparathyroidism. This evidence concerns the gene EMC10 and movement disorder.